Medicine guide
Skyrizi
600 mg/10mL · Injection
- Prescription only
- Interleukin-23 Antagonist
- Active substance
- Risankizumab-Rzaa
- Made by
- AbbVie Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicines
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | AbbVie Inc. |
|---|---|
| Active substance | Risankizumab-Rzaa |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 600 mg/10mL |
| Form | Injection |
| Route | Intravenous |
| Packs | 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE |
| NDC | 0074-5015 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection3 products
- 150 mg/mL
- 180 mg/1.2mL
- 600 mg/10mL
- Kit1 products
- Injection, Solution1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.